Navigation Links
Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
Date:6/19/2008

SYDNEY, Australia, June 19 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that the company and the U.S. Food and Drug Administration (FDA) have reached agreement on the phase 3 registration trial of Bronchitol for bronchiectasis via the Special Protocol Assessment process.

The SPA process allows for FDA evaluation of a clinical trial protocol intended to form the primary basis of an efficacy claim in support of a New Drug Application, and provides an agreement that the study design, including trial size, clinical endpoints and/or data analyses are acceptable to the FDA.

Pharmaxis previously agreed on the trial design with the European regulatory agency (EMEA). This trial will therefore form the basis of a marketing application in both the U.S. and Europe.

The phase 3 trial has been designed in collaboration with internationally renowned experts in the field of bronchiectasis and will be a randomized, placebo controlled, double-blind investigation of Bronchitol twice daily in approximately 350 adults with bronchiectasis. Participants will be treated for 52 weeks and the primary endpoints are reduction in frequency of exacerbations and improvement in quality of life. Secondary endpoints include time to first exacerbation and duration of exacerbation. Additional secondary endpoints are antibiotic use, sputum volume, exercise tolerance and lung function measurements. The trial includes health economic analysis and will be conducted in centers across Europe and the U.S.

This trial is the second Phase III study to be undertaken for Bronchitol in bronchiectasis and follows the completion of a successful shorter trial reported last year.

Pharmaxis CEO, Alan Robertson, said the company was pleased to have concluded its discussions with the FDA and the EMEA.

''We believe this phase 3 trial design will allow us to thoroughly demonstrate the clinical benefits of Bronchitol in a patient populat
'/>"/>

SOURCE Pharmaxis Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmaxis Establishes Named Patient Program for Bronchitol
2. Pharmaxis Long-Term Safety Study of Bronchitol Completes
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
5. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
6. Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
7. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
8. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
9. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
10. Specialized Genasense(R) Clinical Trials Featured at AACR Meeting
11. Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... PHILADELPHIA , April 24, 2015  Lannett Company, ... has amended and increased its five-year revolving credit facility ... includes an accordion feature that will allow the company ... an additional $30.0 million, subject to securing additional commitments ... date of the credit facility remains December 18, 2018. ...
(Date:4/24/2015)... Mass. , April 24, 2015  Blueprint ... BLU-554, a selective and potent inhibitor of fibroblast ... activity in models of hepatocellular carcinoma (HCC) that ... therapeutic candidate, BLU-554 induced complete tumor regression in ... an FGFR4-activating ligand at the highest dose levels. ...
(Date:4/23/2015)... , April 23, 2015 Once again, ... strengthening our commitment to patient safety. BeaconMedaes, ... fight against infectious disease. The next generation ... Medical gas sensors are now mounted in the assembly, ... need to open ceiling tiles potentially releasing dust spores ...
Breaking Medicine Technology:Lannett Expands Revolving Credit Facility To $120 Million 2Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 2Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 3BeaconMedaes launches new Zone Valve Box Assembly 2
... REDWOOD CITY, Calif., Aug. 17 Cardica, Inc. (Nasdaq: ... Intuitive Surgical, Inc. have entered into a license agreement ... intellectual property, which relates to tissue cutting, stapling and ... to the license agreement, Cardica and Intuitive may also ...
... (Nasdaq: BMRN ) announced today that it ... company developing enzyme replacement therapies (ERT) for the treatment ... ZC-701, a novel fusion of insulin-like growth factor 2 ... Under the terms of the agreement, BioMarin ...
Cached Medicine Technology:Cardica and Intuitive Surgical Enter Into License Agreement 2Cardica and Intuitive Surgical Enter Into License Agreement 3BioMarin Acquires ZyStor Therapeutics, Inc. 2BioMarin Acquires ZyStor Therapeutics, Inc. 3BioMarin Acquires ZyStor Therapeutics, Inc. 4BioMarin Acquires ZyStor Therapeutics, Inc. 5
(Date:4/25/2015)... Sports controversies continue to revolve around issues of ... the case with the Miami Dolphins and Richie Incognito, or off ... Ray Rice domestic abuse case. In a recent episode of ... the implications of locker room culture on teams. He examines what ... should do to improve the locker room as a work place. ...
(Date:4/24/2015)... Illinois (PRWEB) April 24, 2015 Multi ... includes septic tank pumping ( http://www.zeitersseptics.com/multi-customer-discount.html ) of 1000-1500 ... to start the program. This does not include any ... applicable. Save $25-$65 per person. If someone is part ... or two tanks totaling approximately 2500 gallons or more, ...
(Date:4/24/2015)... York, New York (PRWEB) April 24, 2015 ... continue to move forward in the federal multidistrict ... South Carolina. According to court documents, the parties ... Report on April 16th detailing, among other things, ... report notes that counsel for both plaintiffs and ...
(Date:4/24/2015)... Carinsurancequotesinfo.com has released a new blog ... to qualify for auto insurance as a ... auto insurance online, without having to follow a special ... parents can reduce their auto insurance expenses. The tips ... explained. , Clients can now visit an insurance ...
(Date:4/24/2015)... Joseph, Missouri (PRWEB) April 24, 2015 ... for veterinarians , UGA is now proud to be ... the care of 16,000 animals a year. This partnership ... care for their animals. , After providing an ... Missouri Veterinary Medical Teaching Hospital (VMTH) wanted to increase ...
Breaking Medicine News(10 mins):Health News:David Steele Discusses Locker Room Culture on SCI TV 2Health News:David Steele Discusses Locker Room Culture on SCI TV 3Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2
... ORLANDO, Fla., Aug. 19 Valensa International ... dramatically increased the stability and shelf-life of the powerful, ... 7-year shelf-life study of its Zanthin(R) natural astaxanthin that ... Haematococcus pluvialis, bolstered by Valensa,s proprietary O2B(R) Peroxidation Blocker ...
... , , WASHINGTON, Aug. 19 ... August 2009: , , The "Bulletin," which is ... ), brings you the latest issues and news affecting people with ... , click on "Online mailing list archives," select "NCD-NEWS-L," click on ...
... , ... software-based 3D scanner includes 3D scan data processing capabilities and supports scanning in 360°. ... Vancouver, BC (PRWEB) August 19, ... of FlexScan3D 2.5 , the latest version of its 3D scanning software. New ...
... ... stepper motors presented by NMB. These popular sizes are ideal for medical and industrial applications. ... Chatsworth, CA (PRWEB) August 19, 2009 ... of standard hybrid stepper motors. , , , , ,The standard hybrid line includes the ...
... , COLUMBIA, S.C., Aug. 19 ... technology and knowledge discovery software, announced today that their life science research ... the 200,000 registered user mark . , , (Logo: ... in less than 18 months is very positive and we expect that ...
... , PACE(R) Programs Open Doors to Highlight ... WASHINGTON, Aug. 19 In celebration of National Senior Citizens Day, ... many of the individual Programs of All-inclusive Care for the Elderly ... through health fairs and open houses. Designed to serve individuals ...
Cached Medicine News:Health News:Astaxanthin Stability Breakthrough Achieved by Valensa 2Health News:Astaxanthin Stability Breakthrough Achieved by Valensa 3Health News:National Council on Disability Monthly Bulletin for August 2009 2Health News:National Council on Disability Monthly Bulletin for August 2009 3Health News:National Council on Disability Monthly Bulletin for August 2009 4Health News:National Council on Disability Monthly Bulletin for August 2009 5Health News:National Council on Disability Monthly Bulletin for August 2009 6Health News:National Council on Disability Monthly Bulletin for August 2009 7Health News:3D3 Solutions Unveils FlexScan3D Version 2.5 3D Scanner; New Features Speed Up the 3D Scanning Process 2Health News:NMB's New Series of Standard Hybrid Stepper Motors Now Available 2Health News:Collexis BiomedExperts.com Achieves 200,000 Registered Users 2Health News:Collexis BiomedExperts.com Achieves 200,000 Registered Users 3Health News:National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 2Health News:National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 3
... Insulin-like growth factor I (IGF-I or somatomedin C) ... the liver. It acts as a potent mitogen ... to specific cell-surface receptors. In the circulation, IGF-I ... to regulate the actions of IGF-I by modulating ...
... a potent naturally occurring androgen produced ... cholestenone 5a-reductase [1]. The concentrations ... peripheral tissues, including genital skin and ... in apparent association with the nuclear ...
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
... The BT table comes in two ... movements, and the BT5, which offers five. ... the tables adjust to suit your needs. ... and hand controls, side rails, ankle/foot supports, ...
Medicine Products: